In a recent study using a mouse model with ovarian cancer, inhibitors against DNA MTase augmented the production of immune-stimulatory chemokines such as CXCL9 or 10, and re-sensitized cancer cells to anti-PD-L1 MoAbs [65]. This evidence concerns the gene CD274 and ovarian cancer.